Therapeutics targeting angiogenesis: Genetics and epigenetics, extracellular miRNAs and signaling networks (Review)

International Journal of Molecular Medicine

Volumn 32, Issue 4, 2013, Pages 763-767

  Katoh, Masaru ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

AZD4547; Bevacizumab; Breast cancer; Chitosan; Colorectal cancer; Dovitinib; Field cancerization; Gastric cancer; Lung cancer; Poly(lactic co glycolic acid); Ponatinib; Sorafenib; Sunitinib; Vascular medicine

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; AZD 4547; BEVACIZUMAB; DOVITINIB; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; JAGGED1; MICRORNA; PLASMID VECTOR; PONATINIB; RANIBIZUMAB; RECOMBINANT VASCULOTROPIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SORAFENIB; SUNITINIB; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ANTIANGIOGENIC THERAPY; BASEMENT MEMBRANE; BLEEDING; BLOOD VESSEL PERMEABILITY; CANCER STEM CELL; CANCER THERAPY; CELL THERAPY; DIGESTIVE SYSTEM PERFORATION; ENDOTHELIAL PROGENITOR CELL; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; GASTROINTESTINAL STROMAL TUMOR; GENE AMPLIFICATION; GENE TRANSLOCATION; GENETIC VARIABILITY; GENOTYPE; HEDGEHOG; HERPES SIMPLEX VIRUS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY CARCINOMA; LENTIVIRINAE; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MESENCHYMAL STEM CELL; METASTATIC COLORECTAL CANCER; OCCLUSIVE CEREBROVASCULAR DISEASE; OVARY CANCER; PERIPHERAL VASCULAR DISEASE; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEINURIA; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SYSTEMIC THERAPY; TIGHT JUNCTION;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CELL PROLIFERATION; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; GENOTYPE; HUMANS; MACULAR DEGENERATION; MICRORNAS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883312340     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1444     Document Type: Review

References (36)

1. Kim DS and Hahn Y: Human-specific antisense transcripts induced by the insertion of transposable element. Int J Mol Med 26: 151-157, 2010.
2. Xu L, Elkahloun AG, Candotti F, et al: A novel function of RNAs arising from the long terminal repeat of human endogenous retrovirus 9 in cell cycle arrest. J Virol 87: 25-36, 2012.
3. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C and Mesnard JM: The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 76: 12813-12822, 2002.
4. Arnold J, Zimmerman B, Li M, Lairmore MD and Green PL: Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 112: 3788-3797, 2008.
5. Katsumata K, Ikeda H, Sato M, et al: Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin Immunol 93: 75-80, 1999.
6. Lee JR, Ahn K, Kim YJ, Jung YD and Kim HS: Radiation-induced human endogenous retrovirus (HERV)-R env gene expression by epigenetic control. Radiat Res 178: 379-384, 2012.
7. Reiche J, Pauli G and Ellerbrok H: Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation. Melanoma Res 20: 435-440, 2010.
8. Toufaily C, Landry S, Leib-Mosch C, Rassart E and Barbeau B: Activation of LTRs from different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators. Viruses 3: 2146-2159, 2011.
9. Kwun HJ, Han HJ, Lee WJ, Kim HS and Jang KL: Transactivation of the human endogenous retrovirus K long terminal repeat by herpes simplex virus type 1 immediate early protein 0. Virus Res 86: 93-100, 2002.
10. Ruprecht K, Obojes K, Wengel V, et al: Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J Neurovirol 12: 65-71, 2006.
11. Nellaker C, Yao Y, Jones-Brando L, Mallet F, Yolken RH and Karlsson H: Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology 3: 44, 2006.
12. Katoh I, Mirova A, Kurata S, et al: Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M. Neoplasia 13: 1081-1092, 2011.
13. Lee YN and Bieniasz PD: Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 3: e10, 2007.
14. Lee JW and Kim HS: Endogenous retrovirus HERV-I LTR family in primates: sequences, phylogeny, and evolution. Arch Virol 151: 1651-1658, 2006.
15. Yi JM and Kim HS: Evolutionary implication of human endogenous retrovirus HERV-H family. J Hum Genet 49: 215-219, 2004.
16. Mager DL and Henthorn PS: Identification of a retrovirus-like repetitive element in human DNA. Proc Natl Acad Sci USA 81: 7510-7514, 1984.
17. Blond JL, Beseme F, Duret L, et al: Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 73: 1175-1185, 1999.
18. Gifford R and Tristem M: The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 26: 291-315, 2003.
19. Strazzullo M, Parisi T, Di Cristofano A, Rocchi M and La Mantia G: Characterization and genomic mapping of chimeric ERV9 endogenous retroviruses-host gene transcripts. Gene 206: 77-83, 1998.
20. Tonjes RR, Czauderna F and Kurth R: Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol 73: 9187-9195, 1999.
21. Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW and Johanning GL: Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22: 1528-1535, 2003.
22. Herbst H, Sauter M and Mueller-Lantzsch N: Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors. Am J Pathol 149: 1727-1735, 1996.
23. Huh JW, Kim DS, Kang DW, et al: Transcriptional regulation of GSDML gene by antisense-oriented HERV-H LTR element. Arch Virol 153: 1201-1205, 2008.
24. Sun Q, Yang J, Xing G, Sun Q, Zhang L and He F: Expression of GSDML associates with tumor progression in uterine cervix cancer. Transl Oncol 1: 73-83, 2008.
25. Backman SA, Ghazarian D, So K, et al: Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci USA 101: 1725-1730, 2004.
26. Tsirmoula S, Dimas K, Hatziapostolou M, Lamprou M, Ravazoula P and Papadimitriou E: Implications of pleiotrophin in human PC3 prostate cancer cell growth in vivo. Cancer Sci 103: 1826-1832, 2012.
27. Landry JR, Rouhi A, Medstrand P and Mager DL: The Opitz syndrome gene Mid1 is transcribed from a human endogenous retroviral promoter. Mol Biol Evol 19: 1934-1942, 2002.
28. Kowalski PE, Freeman JD and Mager DL: Intergenic splicing between a HERV-H endogenous retrovirus and two adjacent human genes. Genomics 57: 371-379, 1999.
29. Gebefügi E, Brunmeir R, Weierich C, Wolff H, Brack-Werner R and Leib M: Activation of a HERV-H LTR induces expression of an aberrant calbindin protein in human prostate carcinoma cells. Retrovirology 6 (Suppl 2): P48, 2009.
30. Wang S and Olson EN: AngiomiRs ? key regulators of angiogenesis. Curr Opin Genet Dev 19: 205-211, 2009.
31. Gallo A, Tandon M, Alevizos I and Illei GG: The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7: e30679, 2012.
32. Turchinovich A, Weiz L and Burwinkel B: Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 37: 460-465, 2012.
33. Banigan MG, Kao PF, Kozubek JA, et al: Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS One 8: e48814, 2013.
34. Cantaluppi V, Gatti S, Medica D, et al: Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int 82: 412-427, 2012.
35. Lässer C: Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors. Expert Opin Biol Ther 12 (Suppl 1): S189-S197, 2012.
36. Qin D, Trenkwalder T, Lee S, et al: Early vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia. PLoS One 8: e61831, 2013.